Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080931408> ?p ?o ?g. }
- W3080931408 endingPage "140" @default.
- W3080931408 startingPage "135" @default.
- W3080931408 abstract "BACKGROUND. Incidental homogeneous renal masses are frequently encountered at portal venous phase CT. The American College of Radiology Incidental Findings Committee's white paper on renal masses recommends additional imaging for incidental homogeneous renal masses greater than 20 HU, but single-center data and the Bosniak classification version 2019 suggest the optimal attenuation threshold for detecting solid masses should be higher. OBJECTIVE. The purpose of this article is to determine the clinical importance of small (10-40 mm) incidentally detected homogeneous renal masses measuring 21-39 HU at portal venous phase CT. METHODS. We performed a 12-institution retrospective cohort study of adult patients who underwent portal venous phase CT for a nonrenal indication. The date of the first CT at each institution ranged from January 1, 2008, to January 1, 2014. Consecutive reports from 12,167 portal venous phase CT examinations were evaluated. Images were reviewed for 4529 CT examinations whose report described a focal renal mass. Eligible masses were 10-40 mm, well-defined, subjectively homogeneous, and 21-39 HU. Of these, masses that were shown to be solid without macroscopic fat; classified as Bosniak IIF, III, or IV; or confirmed to be malignant were considered clinically important. The reference standard was renal mass protocol CT or MRI, ultrasound of definitively benign cysts or solid masses, single-phase contrast-enhanced CT or unenhanced MRI showing no growth or morphologic change for 5 years or more, or clinical follow-up 5 years or greater. A reference standard was available for 346 masses in 300 patients. The 95% CIs were calculated using the binomial exact method. RESULTS. Eligible masses were identified in 4.2% of patients (514/12,167; 95% CI, 3.9-4.6%). Of 346 masses with a reference standard, none were clinically important (0%; 95% CI, 0-0.9%). Mean mass size was 17 mm; 72% (248/346) measured 21-30 HU, and 28% (98/346) measured 31-39 HU. CONCLUSION. Incidental small homogeneous renal masses measuring 21-39 HU at portal venous phase CT are common and highly likely benign. CLINICAL IMPACT. The change in attenuation threshold signifying the need for additional imaging from greater than 20 HU to greater than 30 HU proposed by the Bosniak classification version 2019 is supported." @default.
- W3080931408 created "2020-09-01" @default.
- W3080931408 creator A5007355469 @default.
- W3080931408 creator A5010788589 @default.
- W3080931408 creator A5011474939 @default.
- W3080931408 creator A5013268701 @default.
- W3080931408 creator A5016002613 @default.
- W3080931408 creator A5023742645 @default.
- W3080931408 creator A5025929715 @default.
- W3080931408 creator A5027981917 @default.
- W3080931408 creator A5028366125 @default.
- W3080931408 creator A5029241557 @default.
- W3080931408 creator A5044774339 @default.
- W3080931408 creator A5052332043 @default.
- W3080931408 creator A5055503583 @default.
- W3080931408 creator A5060220628 @default.
- W3080931408 creator A5060588704 @default.
- W3080931408 creator A5060923901 @default.
- W3080931408 creator A5062288067 @default.
- W3080931408 creator A5069468876 @default.
- W3080931408 creator A5072006387 @default.
- W3080931408 creator A5074780461 @default.
- W3080931408 creator A5074869669 @default.
- W3080931408 creator A5078439800 @default.
- W3080931408 creator A5087915289 @default.
- W3080931408 creator A5089591447 @default.
- W3080931408 creator A5089984017 @default.
- W3080931408 date "2021-07-01" @default.
- W3080931408 modified "2023-10-04" @default.
- W3080931408 title "Clinical Importance of Incidental Homogeneous Renal Masses That Measure 10–40 mm and 21–39 HU at Portal Venous Phase CT: A 12-Institution Retrospective Cohort Study" @default.
- W3080931408 cites W1976582844 @default.
- W3080931408 cites W1982523995 @default.
- W3080931408 cites W2006252528 @default.
- W3080931408 cites W2062601435 @default.
- W3080931408 cites W2101408891 @default.
- W3080931408 cites W2106274555 @default.
- W3080931408 cites W2106287201 @default.
- W3080931408 cites W2136665827 @default.
- W3080931408 cites W2139102417 @default.
- W3080931408 cites W2147264650 @default.
- W3080931408 cites W2156359616 @default.
- W3080931408 cites W2158988274 @default.
- W3080931408 cites W2163748372 @default.
- W3080931408 cites W2169508072 @default.
- W3080931408 cites W2171351086 @default.
- W3080931408 cites W2272378317 @default.
- W3080931408 cites W2397615757 @default.
- W3080931408 cites W2600206904 @default.
- W3080931408 cites W2680371805 @default.
- W3080931408 cites W2726299968 @default.
- W3080931408 cites W2768348116 @default.
- W3080931408 cites W2880596017 @default.
- W3080931408 cites W2891661826 @default.
- W3080931408 cites W2950537929 @default.
- W3080931408 cites W3071117894 @default.
- W3080931408 doi "https://doi.org/10.2214/ajr.20.24245" @default.
- W3080931408 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32845714" @default.
- W3080931408 hasPublicationYear "2021" @default.
- W3080931408 type Work @default.
- W3080931408 sameAs 3080931408 @default.
- W3080931408 citedByCount "9" @default.
- W3080931408 countsByYear W30809314082021 @default.
- W3080931408 countsByYear W30809314082022 @default.
- W3080931408 countsByYear W30809314082023 @default.
- W3080931408 crossrefType "journal-article" @default.
- W3080931408 hasAuthorship W3080931408A5007355469 @default.
- W3080931408 hasAuthorship W3080931408A5010788589 @default.
- W3080931408 hasAuthorship W3080931408A5011474939 @default.
- W3080931408 hasAuthorship W3080931408A5013268701 @default.
- W3080931408 hasAuthorship W3080931408A5016002613 @default.
- W3080931408 hasAuthorship W3080931408A5023742645 @default.
- W3080931408 hasAuthorship W3080931408A5025929715 @default.
- W3080931408 hasAuthorship W3080931408A5027981917 @default.
- W3080931408 hasAuthorship W3080931408A5028366125 @default.
- W3080931408 hasAuthorship W3080931408A5029241557 @default.
- W3080931408 hasAuthorship W3080931408A5044774339 @default.
- W3080931408 hasAuthorship W3080931408A5052332043 @default.
- W3080931408 hasAuthorship W3080931408A5055503583 @default.
- W3080931408 hasAuthorship W3080931408A5060220628 @default.
- W3080931408 hasAuthorship W3080931408A5060588704 @default.
- W3080931408 hasAuthorship W3080931408A5060923901 @default.
- W3080931408 hasAuthorship W3080931408A5062288067 @default.
- W3080931408 hasAuthorship W3080931408A5069468876 @default.
- W3080931408 hasAuthorship W3080931408A5072006387 @default.
- W3080931408 hasAuthorship W3080931408A5074780461 @default.
- W3080931408 hasAuthorship W3080931408A5074869669 @default.
- W3080931408 hasAuthorship W3080931408A5078439800 @default.
- W3080931408 hasAuthorship W3080931408A5087915289 @default.
- W3080931408 hasAuthorship W3080931408A5089591447 @default.
- W3080931408 hasAuthorship W3080931408A5089984017 @default.
- W3080931408 hasConcept C121332964 @default.
- W3080931408 hasConcept C126838900 @default.
- W3080931408 hasConcept C141071460 @default.
- W3080931408 hasConcept C143753070 @default.
- W3080931408 hasConcept C167135981 @default.
- W3080931408 hasConcept C2989005 @default.
- W3080931408 hasConcept C66882249 @default.
- W3080931408 hasConcept C71924100 @default.